SCHEMBL13716342

SCHEMBL13716342

Cc1c#cncc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13795773 0.67
SCHEMBL947 0.56
SCHEMBL53381 0.56
SCHEMBL14295011 0.51
SCHEMBL1310594 0.46 LMNA (0.50)
P-Xylene SCHEMBL497786 0.45 ACHE (0.80)
SCHEMBL2567092 0.44
SCHEMBL651684 0.43
P-Xylene SCHEMBL11772917 0.42 ACHE (1.00)
P-Xylene SCHEMBL771 0.42

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4001277-A2 BICYCLIC COMPOUNDS FOR DIAGNOSIS AND THERAPY AC Immune SA (CH) 2022-05-25 EP disclosed
US-20130109684-A1 GRP94 INHIBITORS UNIVERSITY OF KANSAS (US) 2013-05-02 US disclosed
EP-1383731-B1 BIARYL COMPOUNDS AS SERINE PROTEASE INHIBITORS BIOCRYST PHARM INC (US) 2009-08-05 EP disclosed